Dear all,
Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
On-demand seminar: Ethnic Bridging in Drug Development
We record all of our free online seminars, so that you have the possibility to watch them on-demand. Our latest on-demand online seminar is titled: "Ethnic Bridging in Drug Development: Science-approach and Practical Experience with Asian Study Participants". Profil's Director Clinical Pharmacology Dr. Grit Andersen talked about the chances and challenges of ethnic bridging studies and our experience here at Profil. Watch here.
What role does COVID-19 play in the pathogenesis of diabetes mellitus
In our latest blog article Dr. Theresa Herbrand, Scientific Study Advisor and Research Physician here at Profil, discusses the impact of COVID-19 as a risk factor for the pathogenesis of diabetes mellitus and points out further challenges and problems in the future. Read more.
The effects of subcutaneous tirzepatide on pancreatic islet function
Read our latest publication authored by Profil's Co-Founder Dr. Tim Heise about recent study results on subcutaneous tirzepatide compared to semaglutide or placebo on pancreatic islet function and insulin sensitivity in adult patients with type 2 diabetes mellitus. Read more
Meet us at upcoming conferences
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise! Upcoming events in 2022:
CPhI worldwide, November 1 - 3, 2022, Frankfurt, Germany